Treatment of common slowly-progressive PKD is usually conservative

PKD Treatment

Treatment of common slowly-progressive PKD is usually conservative
Over the years linked patients with PKD in different communities, sought to stimulate interest in this disorder among health professionals, and lobbied for research into IgAN.

As this begins to happen (sometimes over many years), nephrologists begin providing more frequent follow-up and appropriate pre-esrd care. Additional information on some aspects of treatment is given in the following paragraphs.
The inflammation is produced by a buildup of a substance called immunoglobulin A (IgA) in the kidneys. IgA is a type of antibody manufactured by the immune system.IgA nephropathy leads to renal (kidney) failure and other related complications. It may be acute (attacking quickly and suddenly) or chronic.

patients with PKD Treatment considered benign in the classic descriptions and for a decade, is perhaps the most challenging primary glomerulonephritis in which to evaluate pathogenesis, its impact on renal services and to discover effective treatments for IgA progressive forms
there is no standard specific treatment for chronic PKD Treatment.Treatment is given in support of specific symptoms, such as hypertension and edema. Some high blood pressure medications appear to have renal-protective effects that go beyond their ability to lower blood pressure, and one these may be prescribed even if the blood pressure is not yet elevated.
Treatment of common slowly-progressive PKD is usually conservative (blood pressure medications), while rapidly-progressive IgAN may be treated more aggressively (steroids, immunosuppressants). As chronic IgAN progresses, the patient will eventually start showing symptoms of chronic renal failure.


http://www.sjzkidneyhospital.com/tags.php?/PKD+Treatment/